Failure to Satisfy Listing Rule (Form 8-K)

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On September 29, 2026, the Company received written notice from the NYSE American LLC announcing that the NYSE American would be commencing proceedings to delist the Company's common stock from the NYSE American and that trading would be suspended immediately. The NYSE American determined that the Company is no longer suitable for listing on the NYSE American pursuant to Section 1003(f)(v) of the NYSE American Company Guide due to the low selling price of the Company's common stock. The Company will not appeal the NYSE American's determination to delist its common stock. The NYSE American filed a Form 25 on October 1, 2026 to delist the common stock. The delisting will become effective 10 days after the filing of the Form 25.

Following the suspension the Company's common stock is quoted on the OTC Pink Limited Market. The Company intends to apply for quotation on the OTCQB Venture Market. The OTC market is a significantly more limited market than NYSE American, and quotation on the OTC market likely results in a less liquid market for existing and potential holders of the common stock to trade in the common stock and could further depress the trading price of the common stock. The Company can provide no assurance that its common stock will continue to trade on this market, whether broker-dealers will continue to provide public quotes of the common stock on this market, or whether the trading volume of the common stock will be sufficient to provide for an efficient trading market. The transition to over-the-counter markets will not affect the Company's business operations.